Skip to content
6-K

Foreign Interim / Material

TC BIOPHARM (HOLDINGS) PLC

0001493152-24-047610

← back to feed
Filed
Nov 25, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 64.91M sh
Shares Diluted Q2 2024 · Jun 30, 2023 3.49M sh
Capex Q2 2024 · Jun 30, 2024 £20.85K
Capex Q2 2024 · Jun 30, 2023 £158.86K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −£5.14M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −£6.85M
Cash And Equivalents Q2 2024 · Jun 30, 2024 £1M
Cash And Equivalents Q2 2024 · Dec 31, 2023 £2.46M
Stockholders Equity Q2 2024 · Jun 30, 2024 £2M
Stockholders Equity Q2 2024 · Dec 31, 2023 £2.69M
Stockholders Equity Q2 2024 · Jun 30, 2023 £2.37M
Stockholders Equity Q2 2024 · Dec 31, 2022 £331.27K
Current Liabilities Q2 2024 · Jun 30, 2024 £3.53M
Current Liabilities Q2 2024 · Dec 31, 2023 £4.75M
Total Liabilities Q2 2024 · Jun 30, 2024 £4.87M
Total Liabilities Q2 2024 · Dec 31, 2023 £6.25M
Current Assets Q2 2024 · Jun 30, 2024 £3.95M
Current Assets Q2 2024 · Dec 31, 2023 £5.7M
Total Assets Q2 2024 · Jun 30, 2024 £6.87M
Total Assets Q2 2024 · Dec 31, 2023 £8.93M
Eps Diluted Q2 2024 · Jun 30, 2024 −£0.08
Eps Diluted Q2 2024 · Jun 30, 2023 £0.10
Eps Basic Q2 2024 · Jun 30, 2024 −£0.08
Eps Basic Q2 2024 · Jun 30, 2023 £0.12
Sga Expense Q2 2024 · Jun 30, 2024 £3.26M
Sga Expense Q2 2024 · Jun 30, 2023 £3.73M
Rd Expense Q2 2024 · Jun 30, 2024 £2.24M
Rd Expense Q2 2024 · Jun 30, 2023 £4.04M
Net Income Q2 2024 · Jun 30, 2024 −£5.31M
Net Income Q2 2024 · Jun 30, 2023 £357.98K
Operating Income Q2 2024 · Jun 30, 2024 −£5.5M
Operating Income Q2 2024 · Jun 30, 2023 −£7.76M